Objectif The objective of the project is to further develop and take to market the prototype of the wearable bracelet and cloud based IT platform for 24/7 continuous medical supervision. This is the world’s first wearable health monitoring platform for automated, continuous supervision of pulmonary, heart and sleep related diseases generating preventive alert. This exploits a patented and revolutionary wrist blood oxygen sensing technology called trans-illumination pulse oximetry. Existing systems use a fingertip monitor which is both uncomfortable to wear and has to be connected to bedside or portable machinery and is prone to disconnection and damage in an active environment e.g. on children, and during sleep. This robustness and ease of use (requiring less medical intervention to set up) will reduce the costs in use. The current prototype (TRL6+ demonstrated in a relevant environment and first clinical trials) needs re-engineering to a more acceptable size as part of the development to a saleable product. It is important for widespread acceptance by patients that the device is small and comfortable and does not look like a medical monitoring device. The Oxitone bracelet pulse oximetry health monitor continuously measures, processes, transmits and documents patients’ key vitals taken entirely from the wrist and generates a Dynamic Health Status with minute (60 second) resolution. Oxitone’s advanced algorithm will enable preventive and emergency alert based on real-time correlative analysis of the key vital signs that includes blood oxygen saturation, pulse rate and variability, breathing rate, skin temperature, medical grade activity and sleep pattern. In addition to the wearable platform we offer an advanced mobile health application and Cloud portal which traces, analyses and alerts patient’s health status in real time. Champ scientifique social scienceseconomics and businessbusiness and managementinnovation managementengineering and technologymedical engineeringwearable medical technology Mots‑clés blood oxygen sensing technology Programme(s) H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme H2020-EU.3.1.3. - Treating and managing disease Thème(s) PHC-12-2014-1 - Clinical research for the validation of biomarkers and/or diagnostic medical devices Appel à propositions H2020-SMEInst-2014-2015 Voir d’autres projets de cet appel Sous appel H2020-SMEINST-1-2014 Régime de financement SME-1 - SME instrument phase 1 Coordinateur OXITONE MEDICAL LTD Contribution nette de l'UE € 50 000,00 Adresse TZOMET ABBA HILLEL NORTH INDUSTRIAL ZONE 78172 Ashkelon Israël Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 71 429,00
